Abstract
Single-nucleotide polymorphisms and locus amplification link the NF-κB transcription factor c-Rel to human autoimmune diseases and B cell lymphomas, respectively. However, the functional consequences of enhanced c-Rel levels remain enigmatic. Here, we overexpressed c-Rel specifically in mouse B cells from BAC-transgenic gene loci and demonstrate that c-Rel protein levels linearly dictated expansion of germinal center B (GCB) cells and isotype-switched plasma cells. c-Rel expression in B cells of otherwise c-Rel-deficient mice fully rescued terminal B cell differentiation, underscoring its critical B cell-intrinsic roles. Unexpectedly, in GCB cells transcription-independent regulation produced the highest c-Rel protein levels among B cell subsets. In c-Rel-overexpressing GCB cells this caused enhanced nuclear translocation, a profoundly altered transcriptional program, and increased proliferation. Finally, we provide a link between c-Rel gain and autoimmunity by showing that c-Rel overexpression in B cells caused autoantibody production and renal immune complex deposition.
Introduction
The NF-κB signaling pathway is a master regulator of the immune system, with the transcription factor c-Rel identified as a key player in B cell biology. Genome-wide association studies (GWAS) have linked polymorphisms in the REL locus to various autoimmune conditions, including rheumatoid arthritis and lupus, while gene amplification is common in B-cell lymphomas. Despite these associations, the functional impact of increased c-Rel levels—rather than its loss—has remained unclear due to a lack of suitable gain-of-function models. This study investigates whether B-cell-specific c-Rel overexpression is sufficient to drive pathological immune responses and autoimmunity.
Methods
To explore the effects of c-Rel gain, a conditional transgenic mouse model was developed using Bacterial Artificial Chromosomes (BACs). By modifying the mouse Rel gene locus to include a strong CAG promoter preceded by a "Lox-Stop-Lox" cassette, researchers achieved targeted overexpression. These mice were crossed with CD19Cre or Cγ1Cre lines to drive expression specifically in the B-cell lineage or at the germinal center stage, respectively. Analysis involved intracellular and imaging flow cytometry to quantify c-Rel protein abundance and nuclear translocation, alongside bulk RNA sequencing (SCRB-seq, GSE143156) to map transcriptional changes.
Results
Post-Transcriptional Regulation and Dose-Response
A key finding was the discovery of a post-transcriptional "rheostat" mechanism. Germinal center B (GCB) cells exhibited the highest c-Rel protein levels despite having lower mRNA levels than naive B cells, suggesting a unique stabilization mechanism in this subset. Furthermore, the expansion of GCB and plasma cell populations correlated linearly with c-Rel protein levels, indicating that c-Rel acts as a tunable driver of B-cell activity.
B-Cell Intrinsic Roles and Transcriptional Programming
Rescue experiments in c-Rel-deficient mice demonstrated that B-cell-specific expression of c-Rel is sufficient to restore germinal center formation, confirming its intrinsic role. Transcriptomic analysis revealed that c-Rel gain activates a specific program enriched for cell cycle progression and metabolic fitness, largely mediated through the Myc pathway. This resulted in significantly higher percentages of GCB cells in the S and G2/M phases.
Autoimmunity and Isotype Switching
Overexpression of c-Rel led to a dramatic expansion of isotype-switched plasma cells, with a 14- to 20-fold increase in IgG1-positive cells. Aged transgenic mice spontaneously developed systemic autoimmunity, characterized by high titers of anti-nuclear antibodies (ANAs), anti-dsDNA, and rheumatoid factor. This was accompanied by significant IgG immune complex deposition in the kidneys.
Discussion
This study establishes c-Rel as a critical regulator of B-cell-driven autoimmunity. The identification of a post-transcriptional mechanism for c-Rel stabilization in GCB cells provides a new perspective on how genetic variations at the REL locus might contribute to disease. While c-Rel gain drives significant hyperplasia and autoimmunity, the absence of spontaneous lymphoma suggests that additional oncogenic events are required for malignant transformation. These findings provide a functional link between human genetic data and the pathogenesis of autoimmune diseases.
Summary updated